CAS RN: 156627-42-8
Carbamic acid, [3-hydroxy-1-(hydroxymethyl)propyl]-, 1,1-dimethylethyl ester
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 5g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 156627-42-8
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
5g
≥95%
0
Out of Stock
Shanghai
Inquiry
156627-42-8 / tert-butyl N-(1,4-dihydroxybutan-2-yl)carbamate
Standard CAS: 156627-42-8
Multi CAS: No
Basic Information
copy
CAS
156627-42-8 copy
Multi CAS
No copy
Molecular Formula
C9H19NO4 copy
Molecular Weight
205.250000 copy
Exact Mass
205.131408 copy
SMILES
CC(C)(C)OC(=O)NC(CCO)CO copy
InChI
InChI=1S/C9H19NO4/c1-9(2,3)14-8(13)10-7(6-12)4-5-11/h7,11-12H,4-6H2,1-3H3,(H,10,13) copy
InChIKey
KLRRFBSWOIUAHZ-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
14 copy
Fraction Csp3
0.89 copy
Rotatable bonds
4 copy
H-bond acceptors
4 copy
H-bond donors
3 copy
Molar refractivity
51.95 copy
TPSA
78.79 copy
LogP / Solubility
WLOGP
0.25 copy
MLOGP
0.22 copy
Consensus LogP
0.16 copy
Log S (ESOL)
-1.01 copy
Class (ESOL)
Soluble copy
Log S (Ali)
-1.43 copy
Class (Ali)
Soluble copy
Log S (SILICOS-IT)
-1.69 copy
Class (SILICOS-IT)
Soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.79 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
2 copy